BMC Urology, 2024 · DOI: https://doi.org/10.1186/s12894-024-01457-0 · Published: April 1, 2024
This study reviews the clinical characteristics and molecular mechanisms of spinal cord injury patients with bladder cancer. The goal is to help clinicians better recognize and manage these patients. The review of existing research shows that bladder cancer occurs more frequently and is more deadly in spinal cord injury patients compared to the general population. Squamous cell carcinoma is the most common type of bladder cancer in these patients. Long-term catheter use and urinary tract infections contribute to bladder cancer development. Molecules like NO, MiR 1949 and Rb 1 also play a crucial role.
Establish and implement specific screening protocols for bladder cancer in SCI patients to improve early detection and treatment outcomes.
Further investigate the molecular mechanisms, such as the roles of NO, MiR-1949, and Rb1, to identify potential therapeutic targets for bladder cancer in SCI patients.
Promote the use of clean intermittent catheterization (CIC) over long-term indwelling catheters to reduce the risk of urinary tract infections and subsequent bladder cancer development.